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Impact of spatial dispersion, 
evolution, and selection on Ebola 
Zaire Virus epidemic waves
Taj Azarian1, 2, *, Alessandra Lo Presti3, *, Marta Giovanetti3, Eleonora Cella3, Brittany Rife4, 
Alessia Lai5, Gianguglielmo Zehender5, Massimo Ciccozzi3, 6 & Marco Salemi2, 4
Ebola virus Zaire (EBOV) has reemerged in Africa, emphasizing the global importance of this 
pathogen. Amidst the response to the current epidemic, several gaps in our knowledge of EBOV 
evolution are evident. Specifically, uncertainty has been raised regarding the potential emergence 
of more virulent viral variants through amino acid substitutions. Glycoprotein (GP), an essential 
component of the EBOV genome, is highly variable and a potential site for the occurrence of 
advantageous mutations. For this study, we reconstructed the evolutionary history of EBOV by 
analyzing 65 GP sequences from humans and great apes over diverse locations across epidemic 
waves between 1976 and 2014. We show that, although patterns of spatial dispersion throughout 
Africa varied, the evolution of the virus has largely been characterized by neutral genetic drift. 
Therefore, the radical emergence of more transmissible variants is unlikely, a positive finding, which 
is increasingly important on the verge of vaccine deployment.
Ebola virus Zaire (EBOV), a member of the Filoviridae family, is a virulent Category A pathogen that causes 
considerable morbidity and mortality1. The EBOV genome is a linear, non-segmented, single-stranded 
RNA approximately 19,000 nucleotides long, coding for seven structural and one non-structural protein2. 
EBOV causes Ebola viral disease (EVD), characterized by fever, malaise, and other nonspecific symptoms 
such as myalgia, headache, vomiting, and diarrhea3. About 30%–50% patients manifest hemorrhagic 
symptoms4. Moreover, in some severe cases multi-organ dysfunction, including hepatic damage, renal 
failure, and central nervous system involvement occur, leading to shock and death1. The virus was first 
identified in 1976 during the epidemic of hemorrhagic fever in Zaire, now Democratic Republic of 
Congo (DRC), with the epicenter of the outbreak in Yambuku. EBOV appeared again in DRC in 1977 
near Yambuku and subsequent outbreaks among humans have occurred in west-central Africa in distinct 
waves during 1994-1997 and 2001-20055.
The recent and ongoing outbreak of EBOV began in February 2014 in forested areas of Southeastern 
Guinea, and cases have now been reported among several districts of Guinea. The 2014 EBOV outbreak 
has additionally been affecting the West African countries of Liberia, Nigeria, and Sierra Leone and have 
most recently spilled over to Europe and North America6. A total of 8,376 cases, with 4,024 deaths, have 
been reported to the World Health Organization (WHO) as of October 7, 20143. On August 8, 2014, 
WHO declared the Ebola epidemic in West Africa a public health emergency of international concern.
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The role of zoonosis in EBOV transmission is well recognized, yet incompletely understood. Between 
2001 and 2005, 47 dead animals, including 23 great apes (18 gorillas, 5 chimpanzees), were discovered 
in Gabon and DRC. EBOV infection was confirmed for 13 gorillas, three chimpanzees, and one duiker7. 
The ongoing seventh DRC Ebola outbreak has been traced back to a single index case, a pregnant woman 
who butchered a monkey and subsequently spread the infection to four healthcare workers8. Fruit bats 
have also been implicated in harboring the virus9. However, the spatial dispersal of EBOV is incompletely 
explained by a single zoonotic transmission event. More likely, several animals are responsible for bridg-
ing transmission events between epidemic waves10.
With the current epidemic ongoing and new cases reported daily, there is an urgent need to under-
stand the transmission of EBOV in Africa. This requires an understanding of geographic spread of the 
virus in the context of evolutionary factors (i.e. selection) driving the repeated emergence of EBOV in 
Africa, which can be inferred using historical genetic data from previous outbreaks. The spatial dispersal 
can also provide important insights that will allow for assessment of the impact of zoonosis on current 
and past epidemics. Previous phylogenetic analyses of the 2014 Ebola outbreak have focused on the 
phylogenetic relationships among strains isolated from Guinean patients and other sequences of the 
genus Ebolavirus, which includes Bundingyo, Reston, Sudan, Tai Forest and Zaire species6,11. Estimates 
of evolutionary rates have shown that the accumulation of nucleotide substitution has nearly doubled 
during the current epidemic when compared to previous outbreaks and resulted more frequently in 
non-synonymous polymorphisms11,12. These findings suggest that the ecological niche for Ebola may be 
expanding due to the emergence of new genetic variants driven by ongoing positive selection13. However, 
a systematic investigation of how selection has been affecting EBOV spatial dispersion across West Africa 
leading the past and current epidemic waves is still lacking. In this study, we used Bayesian phylogeogra-
phy to reconstruct the spatial spread of the virus since the 1970s and analyzed the posterior distribution 
of phylogenetic trees for evidence of selection along the major backbone of the EBOV genealogies – representing 
major lineages propagating through time from root node to each epidemic outbreak. The results clearly 
indicate that EBOV evolution has consistently been driven by neutral genetic drift, rendering the emer-
gence of even more aggressive variants under positive selection unlikely.
Results
EBOV epidemics were divided into groups based on the temporality of each epidemic wave and phy-
logenetic clustering in the Bayesian analysis (Fig. 1A). The genealogy and spatial dispersion was mapped 
for visualization. The Bayesian Maximum Clade Credibility (MCC) EBOV phylogenetic tree exhibited 
staircase-like topology with focal epidemics in specific geographic areas giving rise to epidemics in sub-
sequent years and leading to the current 2014 epidemics (Fig. 1A). Furthermore, the genealogy illustrated 
the emergence of two lineages after the 1976 epidemic in DRC. The first lineage gave rise to the 1994-
1996 epidemics in Gabon and DRC (Group II), and later to 2001-2002 epidemics in Gabon, Cameroon, 
and Republic of Congo (Group III). The second lineage gave rise to the 2001-2005 epidemics in Gabon 
and Republic of Congo (Group IV). Group IV sequences included EBOV sequences collected from 
humans and great apes that were concurrently infected, highlighting the spillover events that occurred 
during this time point. Last, Group VI represents the current 2014 epidemic in Guinea (Gueckedou and 
Kissidougou) and Sierra Leone (Kailahun District), which emerged from a shared common ancestor with 
sequences from the 2007 epidemic in Luebo, DRC (Group V). The general topologies in the posterior 
distribution of trees (Fig. 1B) were highly consistent with the topology of the MCC tree (Fig. 1A), indi-
cating that this particular topology was well supported given the data.
The phylogenetic structure between distinct epidemics was further investigated by likelihood mapping 
analysis14. The evaluation of all possible quartets (group of four sequences) for each group of sequences 
sampled during distinct EBOV epidemic waves (Fig. 1) demonstrated significant differences in phyloge-
netic signal between epidemics (Supplementary Fig. S1). Most notably, 100% and 93% of the quartets 
from the 2007 epidemic in Luebo, DRC (Fig.  1 - Group V) and the current 2014 epidemic in Sierra 
Leone and Guinea (Fig.  1 - Group VI), respectively, were distributed in the center of the likelihood 
map (Fig. 2A). This indicates strong star-like phylogenetic signal reflecting an outburst of new lineages 
due to exponential epidemic spread.15 Interestingly, however, the current 2014 outbreak (group VI), 
as well as the 1976-77 (group I) and 2007-08 epidemics (group V)  were characterized by the lowest 
genetic diversity (Fig. 2B). In contrast, groups II – IV, including strains from the 1990s and early 2000s 
epidemics, were characterized by more structured tree-like topology (star-like signal <50%), and higher 
within groups diversity in case of group II-IV (Fig. 2B), typical of multiple introductions of genetically 
diverse strains evolving from independent lineages over a longer time span. The overall demographic 
history of EBOV was also investigated through a Bayesian coalescent framework16. The GMRF Skygrid 
model – representing non-parametric estimates of virus effective population size (Ne) over time – with a 
relaxed molecular clock was found to be the best fitting model. Molecular clock calibration estimated the 
evolutionary rate of the EBOV GP gene at 1.075 × 10−3 substitutions site−1 per year (95% HPD 1.22 × 10−3, 
9.32 × 10−4) and dated the time of the most recent common ancestor (TMRCA) as 1976 (95% HPD 
1975-1976), in agreement with known epidemiological data5. Ne estimation (i.e. number of genomes 
effectively giving rise to the next generation) indicated an increasing population that peaked in 2007 
www.nature.com/scientificreports/
3Scientific RepoRts | 5:10170 | DOi: 10.1038/srep10170
and subsequently decreased thereafter (Fig. 3), consistent with the decrease in genetic diversity observed 
during the current epidemic.
Phylogeographic analysis illustrated the spatial diffusion of EBOV within the West-African region 
(Supplementary File 1). All geographical migrations were found to be significant (lnBF > 3) when the dis-
persal was assessed using SPREAD. From our analysis, it is likely that migration of EBOV outward from 
Yambuku, DRC, in 1976 served to seed additional regions in DRC and Gabon where the virus emerged 
again in 1994 and 1995, respectively. This lineage then radiated outward causing sporadic outbreaks in 
Gabon, Cameroon, and Republic of Congo from 2001 to 2002. A similar radiating spatial dispersion 
pattern was inferred among Gabon and Republic of Congo strains (Group IV) causing contemporane-
ous human and non-human primate infections. A closely related virus emerged again in Luebo, DRC, 
in 2007, and subsequently led to the current Sierra Leone and Guinea epidemics 2,400 miles away. 
Interestingly, the Republic of Congo and Gabon epidemics spanning 2001 to 2005 (Groups III and IV) 
are geographically compartmentalized, representing two distinct clades on separate lineages of the MCC 
genealogy.
Given the observed variations in spatial dispersion patterns and evolutionary dynamics between differ-
ent epidemics, we then sought to investigate the presence of selective pressures driving the emergence of 
new viral variants during each epidemic wave. We first assessed synonymous (dS) and non-synonymous 
(dN) substitutions among sequence pairs within groups I-VI. While dN/dS increased among groups 
along the backbone of the genealogy leading to the 2014 epidemic, only the 1976-1977 (Group I) sig-
nificantly departed from strict neutrality (i.e., dN > dS) (Supplemental Table 1). A greater number of dN 
mutations was also observed for the 2014 epidemic (Group VI). As these findings provided evidence that 
dN and dS varied across EBOV epidemics, we then compared rates of change at the codon level that 
would result in dN or dS substitutions by independently estimating the evolutionary rate of the 1st + 2nd 
codon position and 3rd codon position. Overall, the evolutionary rate (molecular clock) for the 3rd codon 
position [1.54 (95% HPD 1.32, 1.79)] was significantly greater than the 1st + 2nd codon position [0.73 
(95% HPD 0.60, 0.84)], which suggests low levels, if any, of positive selection (Fig. 4A). Comparison of 
absolute rates of dS and dN substitutions along the backbone path of the EBOV genealogy also showed 
that dS and dN substitutions accumulated at similar rates (Fig.  4B), indicating that the evolution of 
the major of EBOV lineage successfully propagating through time, from its emergence in 1976 until 
Figure 1. Bayesian MCC genealogy and DensiTree representation of posterior distribution of trees 
from Bayesian phylogenetic analysis. (a) Bayesian maximum clade credibility (MCC) tree of EBOV GP 
gene with branch lengths scaled in time by enforcing a relaxed molecular clock. Strain labels are colored 
to indicate the sampling location according to the legend in the figure. Branches labeled with an asterisks 
are well supported, having a posterior probability >0.85. (b) A posterior distribution of trees was obtained 
from Bayesian phylogenetic analysis of EBOV GP gene using GMRF Skygrid model and relaxed molecular 
clock as implemented in BEAST v1.8.0. Tip dates for each node represent the year of isolate collection. 
DensiTree provides a visualization of the posterior distribution of trees and the frequency of node clustering 
for support of clades in the overall topology. Branches are colored based on distinct clades. Well-supported 
branches are indicated by solid colors whereas webs represent little agreement.
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the current epidemic, has been driven by neutral genetic drift. Selection was further investigated by 
evaluation of specific amino acid sites along internal and terminal braches of the genealogy using six 
methods available on the online server (http://www.datamonkey.org)17. The analysis identified only one 
amino acid site (429) that was found to experience significant diversifying selection by three methods, 
and two sites (210 and 664) under significant purifying selection by three and four methods respectively 
(Table 1). When assessing the location of these sites along the branches of the genealogy, however, we 
found that although amino acid site (429) was located on an internal branch, it did not propagate along 
the backbone of the lineage leading to the current epidemic. Remaining mutations were located on ter-
minal branches of the genealogy, likely representing transient polymorphisms.
Figure 2. Comparison of between and within group evolutionary diversity with phylogenetic signal. (a) 
Between group estimates of evolutionary diversity (i.e. nucleotide substitutions per site from averaging over 
all sequence pairs between groups) using maximum composite likelihood model with a gamma distribution. 
Each group represents a distinct group (I - VI) defining a specific epidemic. Percentages along the diagonal 
represent the results from likelihood mapping phylogenetic signal analysis (material and methods). The 
greater the percentage, the higher the “star-like” signal for each clade. (b) Within group estimates for 
evolutionary diversity and standard errors using the maximum composite likelihood model with a gamma 
distribution for six distinct groups representing distinct epidemics.
 SLAC FEL IFEL REL FUBAR MEME
Positive — 429 —
170, 254, 330, 
335, 367, 370, 
376, 377, 388, 




5, 41, 173, 
210, 265, 268, 
437, 495, 496, 
511, 557, 664
210, 495, 
511, 644 — 210, 374, 664 —
Table 1. Sites under diversifying and purifying selection based on analysis of Ebola glycoprotein gene. 
Selection in the Ebola virus genealogy was assessed using the Datamonkey webserver by the following 
methods: SLAC, Single likelihood ancestor counting; FEL, fixed effect likelihood; IFEL, internal FEL; REL, 
random effects likelihood; FUBAR, Fast Unconstrained Bayesian Approximation for Inferring Selection, 
MEME, Mixed Effects Model of Evolution. Sites in bold were found to be under selection by two or more 
methods.
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Discussion
At the time of this writing, the countries of Guinea, Liberia, and Sierra Leone have all reported intense, 
widespread transmission of EBOV, whereas others have had an initial case or cases with localized trans-
mission (Nigeria, Senegal, Spain, and the United States of America). The phylogenetic history of EBOV 
leading to the current epidemics in Africa are seemingly complex, with punctuated focal outbreaks 
emerging in multiple discrete geographic regions over the past four decades. Upon analysis of 65 dated 
EBOV GP gene sequences from several affected countries throughout West Africa, we found that the 
current Sierra Leone epidemic in Kailahun is most closely related to the circulating viral strain in the 
Guinean cities of Kissidougou and Gueckedou (Fig. 1), representing two distinct clades in the Bayesian 
MCC genealogy. The single clade including all Kailihun cases is consistent with a single point source 
introduction followed by direct person-to-person transmission. This is concordant with previous anal-
yses of the current Guinea outbreak, which found that the Guinean epidemic strain emerged from an 
EBOV lineage previously found in DRC, Republic of Congo, and Gabon6,11. Furthermore, the two lin-
eages responsible for the current Guinea and Sierra Leone outbreaks diverged from EBOV responsible 
for the 2007 outbreak in Luebo, DRC. This divergence between the Guinean epidemic from the Central 
African lineage has previously been estimated to have occured in 200211.
The spread of EBOV from Central to West Africa may involve movement of people and animals, 
increasingly connected by expanding populations and improved infrastructure (i.e. roads). Pigott et al. 
(2014) recently estimated that zoonotic transmission is possible in 22 countries of Central and West 
Africa, encompassing a population greater than 22 million13. In comparison to previous Central Africa 
outbreaks in Congo, 1995 and Uganda, 2000, recent studies have demonstrated that the transmission 
dynamics of the current epidemics are comparable in terms of reproductive rate, serial interval, and 
case fatality ratio18. However, EBOV transmission dynamics in Central and West African are seemingly 
different. In West Africa, villages are linked by an extensive transportation network, whereas in Central 
Africa the affected villages are remote and poorly connected8. Therefore, the dissemination patterns 
may vary based on geography, in concert with the epizootic epidemiology of EBOV in and among ani-
mal vectors. Furthermore, previous EBOV spread rates have been estimated at 50 km per year10, which 
complicates the explanation of the nearly 3,900 km traversed in the migration from Central to West 
Africa over a seven year period. While the introduction into West Africa has yet to be explained, it is 
evident that there are strong epizootic and zoonotic components to EBOV transmission. For example, 
the Republic of Congo and Gabon epidemics spanning 2001 to 2005 (Groups III and IV) are phylo-
geographically distinct. Notably, Group IV (Fig.  1A) contains both human and great ape strains from 
Republic of Congo and Gabon epidemics on a single, well-supported monophyletic clade with high 
within-group diversity, suggesting contemporaneous epidemics in humans and animals and multiple 
non-human-primate-to-human spillover events7,19. The compartmentalization of these epidemics sug-
gests variations in reservoirs and intermediate non-human primate host species, as has been previously 
suggested5.
GP is the most widely studied region of the EBOV genome, having an evolutionary rate ideal for 
phylogenetic studies of this timescale20,21. Its expression on the virion surface is responsible for host cell 
attachment and fusion, making it an essential component of pathogenicity as well as a potential vaccine 
target22,23. Yet, few studies have comprehensively assessed selection in the GP gene24. Our estimate of 
the evolutionary rate of the GP gene was 1.075 × 10−3 substitutions site−1 per year (95% HPD 1.22 × 10−3, 
Figure 3. Effective population size (Ne) estimates from Bayesian phylogenetic analysis. The solid black 
line and the shaded blue upper and lower bounds represent, respectively, median and 95% high posterior 
density (95% HPD) intervals estimates of Ne over time. Ne values were estimated in BEAST package v1.8.0 
employing a non-parametric Gaussian Markov randomfield (GMRF) Skygrid evolutionary model assuming a 
relaxed clock.
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9.32 × 10−4), consistent with previous studies11, and Ne reconstruction demonstrated an exponentially 
increasing population. Despite varying patterns of spatial dispersal and epidemic origin, the central find-
ing of the current study is that EBOV evolution, at least after the first known epidemic wave in 1976-77, 
has largely been driven by neutral genetic drift. There was some evidence that dN/dS has varied across 
epidemic waves but, excluding the initial 1976-77 epidemic when there were no observed dS substitu-
tions, deviations from neutrality were not statistically significant. Furthermore, amino acid substitutions 
were mostly transient, either located on terminal branches of the genealogy or removed by purifying 
selection. Investigation of site-specific selection only identified one site on an internal branch that was 
significant for positive selection. Importantly, however, no amino acid substitutions were located on 
backbone branches leading to the current 2014 epidemic. Overall, the rates of dN and dS did not signif-
icantly vary between epidemic waves, providing little evidence that selection acting upon the GP gene is 
driving EBOV evolution. Given that we observed a greater proportion of dN than dS substitutions within 
the 2014 clade (Group VI), we cannot exclude the possibility that advantageous mutations could occur 
in the future and become fixed in the population. Yet, it is noteworthy that while clades with dN/dS > 1 
were observed during past epidemics, these variants did not propagate through time.
The proline to leucine substituion at amino acid site 429 in the Mucin-like domain (MLD, nucleotides 
1,285-1,287) occurred twice along the EBOV genealogy, once after the bottleneck following Group I, with 
the diverging Groups II and III possessing the substitution, and again along the branch leading to the 
current 2014 epidemic. Interestingly, there was a reversion of leucine to proline on a terminal branch of 
Group II (strain 4KI). Although the MLD is dispensable for EBOV infections in vitro25,26 and is the least 
conserved of the GP domains27 it has been determined to have several functions, including enhancing 
viral adhesion28,29 and protecting conserved regions of GP from antibody recognition30,31. Therefore, 
the potential effect of this mutation on virulence and/or pathogenicity should be further investigated. 
Unfortunately, we were unable to identify the specific location of this amino acid and the potential 
effect of its change on local structure because the crystal structure of this highly flexible domain has 
not yet been determined. Meanwhile, the two sites found to be under purifying selection were located 
on terminal branches of the genealogy. Overall, together with the observation of equivalent increases in 
dN and dS across the genealogy, it is evident that EBOV evolution is largely driven by neutral genetic 
drift. Furthermore, while it has been observed that the rate of dN is higher among EBOV genomes in 
the current epidemic, there is no evidence yet that any of these mutations are adaptive and/or if they 
will become fixed in the population or removed by purifying selection. Based on the current analysis, we 
posit the latter scenario is more likely12.
The ongoing EBOV epidemics in Central and West Africa continue to claim lives, and it is estimated 
that the epidemics will expand exponentially12. As the transmission dynamics of these epidemics are 
consistent with those previously studied, our analysis provides evidence that the exponential growth 
of cases is attributed to variations in population structure (e.g., mobility) and large-scale transmission 
events, rather than viral factors such as enhanced virulence or transmissibility. Phylogenetic analysis 
of the epidemic has revealed several gaps in our knowledge in Ebola epidemiology. First, it is evident 
that the virus has been circulating in animal populations spanning the 2007 and 2014 epidemics. More 
studies are needed to examine zoonotic transmission and subsequent spillover into human populations, 
which would better explain the spatial rate of spread and the bottlenecks observed between epidemics. 
Figure 4. EBOV absolute non-synonymous and synonymous divergence over time. (a) Posterior 
probability density of evolutionary rates for 1 + 2 (blue) and 3rd (red) codon positions (b) Mean non-
synonymous (dN) and synonymous (dS) divergence along backbone branches from a sub-sample of 
trees from the posterior distribution during the Ebola epidemics are represented by blue and red lines, 
respectively. Dashed lines represent one standard deviation above and below mean dN or dS. The y-axis 
represents the number of nucleotide changes per site.
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Second, while EBOV evolution has until now been characterized by neutral genetic drift, the progressive 
accumulation of mutations during epidemic spread increases the possibility of viral adaptation. Overall, 
continued genomic surveillance of the epidemic is required to assess adaptability and selection, which is 
increasingly important on the verge of vaccine deployment.
Material and methods
Sequence data set. All available Zaire Ebola Virus (EBOV) GP gene sequences, with known sampling 
date and geographical location, were obtained from the National Center for Biotechnology Information 
(http://www.ncbi.nlm.nih.gov/). Due to the overrepresentation of EBOV dated sequences from Sierra 
Leone, a randomization was performed to reduce the number of taxa and unbias the phylogeographical 
reconstruction. Moreover, three partial GP sequences were excluded from the dataset. The final dataset 
included 65 dated GP gene sequences with known geographical location. The sampling dates ranged 
from 1976 to 2014. The sampling locations were Guinea (Gueckedou, n = 2 and Kissidougou, n = 1), 
Gabon (Ivindo, n = 9; BoOue, n = 1; Mendemba, n = 2; Makokou, n = 1; Etoumbi, n = 1; Ekata, n = 1), DRC 
(Yambuku, n = 7; Kikwit, n = 4; Luebo, n = 9), Congo (Mvoula, n = 1; Entsiami, n = 1; Etakangaye, n = 1; 
Olloba, n = 1; Mbandza, n = 1; Lossi, n = 3); and Sierra Leone (Kailahun, n = 19). This dataset was used 
to estimate the evolutionary rate, perform the time-scaled phylogenetic and phylogeographic analysis, 
and assess selection. All sequences were aligned using ClustalX software and edited by using Bio-Edit 
software v.7.0, as previously described32. jModelTest 2 was used to select the simplest evolutionary model 
that adequately fit the sequence data33.
Likelihood mapping analysis and diversity estimates. In addition to testing for phylogenetic 
signal, the analysis of groups of four randomly chosen sequences (quartets) through the process of 
likelihood mapping provides an indication of phylogenetic structure and population expansion14. For 
a quartet, three unrooted tree topologies are possible. The likelihood of each topology is estimated and 
the three likelihoods are reported as a dot in an equilateral triangle (the likelihood map). Three main 
areas in the map can be distinguished: the three corners representing fully resolved tree topologies (i.e., 
the presence of tree-like phylogenetic signal); the center, which represents star-like genealogy, and the 
three areas on the sides indicating network-like genealogy (i.e., presence of recombination or conflicting 
phylogenetic signals). Extensive simulation studies have shown that >50% dots falling within the central 
area indicate substantial star-like signal, or outburst of multiple phylogenetic lineages, often associated 
with exponential epidemic growth14,15. Likelihood mapping analysis was performed using the program 
TREE-PUZZLE34 by analyzing all possible quartets for each of the six groups representing specific epi-
demics. The analysis was then repeated for the entire genealogy. Between and within group divergence/
diversity were determined by estimating the nucleotide substitutions per site over all sequence pairs 
between and within groups using MEGA v6.0635. A maximum composite likelihood model with gamma 
distribution was used to estimate divergence and diversity for each of the six distinct clades/groups.
Evolutionary rate estimates. Evolutionary rates were estimated using a Bayesian Markov chain 
Monte Carlo (MCMC) method implemented in BEAST package v1.8.016,36 employing a non-parametric 
Gaussian Markov randomfield (GMRF) Skygrid16,37,38 evolutionary model and both a strict and relaxed 
clock with an uncorrelated log normal rate distribution. The GMRF Skygrid model provides enhanced 
performance compared to Bayesian skyline plot (BSP) and Bayesian Skyride models by parameterizing 
Ne and smoothing the trajectory. TMRCA is also better estimated since the prior is independent of the 
genealogy. The alignment was partitioned into first + second codon positions and third codon positions. 
An HKY nucleotide substitution model with gamma-distributed rates among sites was selected. Chains 
were conducted for 2 × 108 generations sampled every 20,000 steps for each molecular clock model. 
Posterior probabilities were calculated using the program Tracer v. 1.6 after 10% burn-in. Convergence 
was assessed on the basis of the effective sampling size (ESS) and only parameter estimates with ESS 
values of >200 were accepted. Marginal likelihoods estimates for each model were obtained using path 
sampling and stepping stone analyses39–41. Uncertainty in the estimates was indicated by 95% highest 
posterior density (95% HPD) intervals, and the best fitting models were selected by a Bayes Factor39,42. 
The GMRF Skygrid model enforcing a relaxed molecular clock was selected as the most appropriate 
representation of the Ebola demographic history42–44.
Time-scaled phylogeography reconstruction. The time-scaled phylogenetic reconstruction and 
the phylogeographic analysis were conducted by using a Bayesian MCMC method implemented in 
BEAST package v1.8.036,41 implementing the HKY+G nucleotide substitution model with codon parti-
tioning and assuming a relaxed clock with an uncorrelated log normal rate distribution and the GMRF 
Skygrid demographic model (previously selected by a Bayes factor). Statistical support for specific clades 
was obtained by calculating the posterior probability of each monophyletic clade. MCMC chains were 
run for at least 200 million generations and sampled every 20,000 steps. The continuous time MCMC 
process over discrete sampling locations implemented in BEAST v1.8.045 was used for the phylogeo-
graphic analysis by implementing the Bayesian Stochastic Search Variable Selection (BSSVS) model, 
which allows diffusion rates to be zero with a positive prior probability. Comparison of the posterior 
and prior probabilities of the individual rates being zero provided a formal BF for testing the significance 
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of the linkages between locations. Rates with a lnBF of >3 were considered well supported and formed 
the migration pathway. The maximum clade credibility (MCC) tree (the tree with the largest product of 
posterior clade probabilities) was selected from the posterior tree distribution after a 10% burn-in using 
TreeAnnotator v1.8.0. The final trees were manipulated in FigTree v1.4.2 for display purposes. The poste-
rior distribution of trees was also visualized with DensiTree46. In the DensiTree, well-supported branches 
are designated by solid colored areas, while webs represent less agreement. The migration routes were 
visualized using SPREAD v1.0.6 and mapped with ArcGIS v10.1.
Selection analysis. MEGA6 was used to estimate the mean synonymous (dS) and nonsynonymous 
(dN) substitutions for each group of sequences representing distinct epidemic waves based on phyloge-
netic and epidemiological data47. For each group of sequences, the Nei-Gojobori method was used to 
test the hypothesis of dN > dS (i.e. a deviation from strict neutrality) and variance was computed using 
1000 bootstrap replicates48. The number of dS and dN substitutions along the EBOV genealogy were 
then estimated by reconstructing and comparing ancestral sequences along the EBOV trees sampled 
from the posterior distribution from the Bayesian analysis. This approach is an empirical extension of 
the coalescent-based Bayesian molecular clock models49. Branch lengths proportional to either dS or 
dN substitutions were re-estimated using a subsample of 200 trees randomly selected from the poste-
rior distribution obtained by BEAST and dN and dS point estimates over time were plotted. For each 
clock-like tree, estimates were obtained for all, internal, and backbone paths. The backbone path is the 
lineages effectively surviving from the root node to sequences sampled at the last time point. Sites under 
diversifying or purifying selection were assessed using six varying methods available on the Datamonkey 
online server (http://www.datamonkey.org)17. Selection tests included Single likelihood ancestor count-
ing (SLAC), fixed effect likelihood (FEL), internal FEL (IFEL), random effects likelihood (REL), Fast 
Unconstrained Bayesian Approximation for Inferring Selection (FUBAR), and Mixed Effects Model of 
Evolution (MEME)50–52. FEL and IFEL assess selection along all branch and internal braches respectively, 
while REL replicates the Nielson and Yang model implemented in PAML53. Site found to be statistically 
significant for positive or negative selection (P < 0.1, posterior probability >0.9, or Bayes Factor >50) by 
more than two methods were further assessed to identify their location within the EBOV genealogy.
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